The nation of Zimbabwe has rejected a major US healthcare agreement valued at $367m (£272m) spanning five years because of Washington's request for sensitive information.
This rejection became public after a internal memorandum dated December was disclosed, revealing that Head of State Emmerson Mnangagwa deemed the arrangement was "skewed".
An official spokesperson has since stated that the US was requesting biological samples for scientific study and profit but was unwilling to share the resulting advantages from any future treatments.
"We must now begin the challenging and unfortunate task of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had provided over $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for further dialogue to find a agreement agreeable to all parties so the nation's vital HIV treatment initiative can proceed.
Broader Implications
This development follows a similar situation in neighbouring Kenya, where a high court suspended a similar deal with the US following legal challenges were raised about the safety of Kenyans' medical information.
After resuming office recently, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
USAID had administered aid for the US government, but Trump stated its expenditure was "wasteful" and his government was seeking direct bilateral agreements to enhance openness and responsibility.
According to reports, Sixteen nations in Africa have to date signed these new agreements, representing more than $18.3bn in new funding.
Details of the Rejected Agreement
This assistance for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this cooperation might have yielded immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving HIV treatment via US-supported programmes," Tremont commented.
However, official spokesman Nick Mangwana maintained the proposed deal was "unequal".
"The proposal required Zimbabwe to surrender its genetic material and health information over an extended period, with no equivalent assurance of access to any medical innovations – like new medicines or tests – that might be developed from that shared data," his statement read.
"Put simply, our country would supply the raw materials for scientific discovery with no certainty that the end products would be accessible to our citizens should a new disease outbreak emerge."
National Interest and Global Health
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of bilateral deals were undermining structures previously established via the global organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage future global health emergencies.
"This mechanism is designed to ensure that when a country contributes its data, the benefits – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the resources to develop them."
These objections regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We are open to further discussions with our US partners on how subsequent collaboration could be designed in a way that respects the sovereignty and interests of both nations."
Medical Community Response
A leading public health body expressed it understood the government's concerns, but urged that talks need to persist since a large portion of the country's Aids initiatives relied on external financing.
"Where specific concerns exist, including those relating to information security or agreement terms, these can often be addressed through detailed discussion and mutually agreed protections," the group added.
This impasse underscores the complex challenges between accepting vital international aid and protecting national sovereignty in an ever more interconnected world.